Company Filing History:
Years Active: 2022-2024
Title: Nader M Boshta: Innovator in Sulfonamide Compounds
Introduction
Nader M Boshta is a prominent inventor based in Shebin El-Kom, Egypt. He has made significant contributions to the field of medicinal chemistry, particularly in the development of sulfonamide compounds. With a total of 3 patents, his work focuses on innovative solutions for treating various central nervous system (CNS) diseases.
Latest Patents
Boshta's latest patents include Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides. These patents disclose sulfonamide compounds with GPR17 modulating properties. They are particularly useful for treating or preventing a variety of CNS diseases, especially myelinating diseases or disorders.
Career Highlights
Nader M Boshta is currently associated with UCB Pharma GmbH, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic approaches in neurology.
Collaborations
Boshta collaborates with esteemed colleagues such as Christa E Mueller and Cécile Pegurier. Their combined expertise enhances the innovative potential of their research projects.
Conclusion
Nader M Boshta stands out as a key figure in the field of medicinal chemistry, with a focus on developing novel sulfonamide compounds for CNS diseases. His contributions are paving the way for new treatment options and improving patient outcomes.